Jarrett Failing

Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma

Jarrett Failing, Heidi D. Finnes, Lisa A. Kottschade et al. · Melanoma Research · 2016 · 57 citations

Therapeutic Drug Monitoring, Oncology, Clinical Therapeutic +11

Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients

Jesus Vera Aguilera, Jonas Paludo, Robert R. McWilliams et al. · Melanoma Research · 2020 · 48 citations · Full text

Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic melanoma patients

Jarrett Failing, Yiyi Yan, Luis F. Porrata et al. · Melanoma Research · 2017 · 46 citations

Lymphocyte-to-monocyte Ratio, Baseline Lmr, Prognostic Biomarkers +12

Safety of Influenza Vaccine in Patients With Cancer Receiving Pembrolizumab

Jarrett Failing, Thanh P. Ho, Siddhartha Yadav et al. · JCO Oncology Practice · 2020 · 45 citations · Full text

Biomarkers of Hyperprogression and Pseudoprogression with Immune Checkpoint Inhibitor Therapy

Jarrett Failing, Olivia Anna Dudek, Julian A. Marin‐Acevedo et al. · Future Oncology · 2019 · 18 citations

Immunology, Pathology, Checkpoint Inhibitor Therapy +16